We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

Investors in Apellis Pharmaceuticals Inc (Symbol: APLS) saw new options begin trading this week, for the May 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and ...

Apellis Pharmaceuticals Inc (NASDAQ:APLS) is set to release its Q4 2024 earnings on Feb 28, 2025. The consensus estimate for Q4 2024 revenue is $198.35 million, and the earnings are expected to ...

APELLIS PHARMACEUTICALS ($APLS) is expected to release its quarterly earnings data on Friday, February 28th before market open, per Finnhub. Analysts are expecting ...

APLS Chairman John Wahl says they implemented new code changes in public libraries across the state that require libraries to come up with policies that explain how minors would be kept safe from ...

Scotiabank analyst Greg Harrison maintained a Hold rating on Apellis Pharmaceuticals (APLS – Research Report) today and set a price target of $30.00. The company’s shares closed yesterday at ...

In this article, we are going to look at where Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) stands against other biotech stocks. The biotechnology sector is gaining new momentum with better market ...